The overexpression of MMP2 has been found in many malignant tumors.21, 23, 39 In our FFPE samples of grade I‐IV gliomas, the MMP2 level increased with an increase in the WHO grade, suggesting that the MMP2 level is also a potential biomarker to distinguish glioma grade. This evidence concerns the gene MMP2 and central nervous system cancer.